2 Mar 2011 16:20
RNS Number : 2206C
Akers Biosciences, Inc.
02 March 2011
2 March 2011
Akers Biosciences Inc.
(the "Company")
Holdings in Company
Akers Biosciences, Inc (AIM:AKR) was notified on 1 March 2011 that, following a number of recent share disposals, Brittany Capital Management Ltd no longer holds a notifiable interest in the Company.
Enquiries:
Akers Biosciences Thomas A. Nicolette, President and Chief Executive Officer | Tel: + 1 856 848 8698 |
Daniel Stewart & Company plc (Nomad and Broker) Antony Legge / Noelle Greenaway | Tel: + 44 (0) 20 7776 6550 |
M: Communications Ben Simons | Tel: + 44 (0) 20 7920 2340 |
This information is provided by RNS
The company news service from the London Stock Exchange